KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 145 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $35,151,000 | -4.5% | 468,803 | -4.1% | 0.01% | 0.0% |
| Q2 2015 | $36,814,000 | +346.1% | 488,835 | +197.1% | 0.01% | +350.0% |
| Q1 2015 | $8,252,000 | +88.2% | 164,546 | +30.1% | 0.00% | +100.0% |
| Q4 2014 | $4,385,000 | +2.0% | 126,434 | -3.7% | 0.00% | 0.0% |
| Q3 2014 | $4,300,000 | -13.8% | 131,261 | +0.9% | 0.00% | 0.0% |
| Q2 2014 | $4,990,000 | +5.1% | 130,068 | +8.9% | 0.00% | 0.0% |
| Q1 2014 | $4,749,000 | +699.5% | 119,437 | +650.6% | 0.00% | – |
| Q4 2013 | $594,000 | – | 15,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 900,559 | $33,636,000 | 3.14% |
| Redmile Group, LLC | 557,761 | $20,777,000 | 2.56% |
| SENZAR ASSET MANAGEMENT, LLC | 79,000 | $2,951,000 | 2.41% |
| Aureus Asset Management, LLC | 134,465 | $5,022,000 | 1.36% |
| REGENTATLANTIC CAPITAL LLC | 193,454 | $7,226,000 | 0.70% |
| PFM Health Sciences, LP | 831,840 | $31,069,000 | 0.62% |
| EAM Investors, LLC | 55,201 | $2,056,000 | 0.37% |
| Dynamic Technology Lab Private Ltd | 5,560 | $207,000 | 0.34% |
| Polar Capital LLP | 350,000 | $13,038,000 | 0.31% |
| Old West Investment Management, LLC | 10,773 | $402,000 | 0.24% |